Pharmaceutical industry

  1. Video content

    Video caption: AstraZeneca executive: 'The vaccine is clearly effective'

    A coronavirus vaccine produced with the University of Oxford stops 70% of people developing Covid symptoms.

  2. Video content

    Video caption: The startup securing virus test kits for African nations

    Ghana startup mPharma is building reliable supply chains for medications in Africa.

  3. Coronavirus: Campaigners demand vaccine be free and available for all

    Video content

    Video caption: They are asking any future vaccine be without copyright or patent

    They are asking any future vaccine be without copyright or patent

  4. ‘No one bought hand sanitizers before, now we are seeing triple-digit growth’

    Video content

    Video caption: How is the Indian pharma industry changing due to the Covid-19 crisis?
  5. Stirling-based firm to manufacture potential Covid vaccine

    Reevel Alderson

    BBC Scotland Home Affairs correspondent

    Vaccine

    A Scottish life-sciences company is to manufacture a vaccine being trialled to combat the Covid-19 pandemic.

    Stirling-based Symbiosis will manufacture the vaccine for the pharmaceutical giant AstraZeneca as it undergoes clinical trials.

    The vaccine, known as AZD 1222, is currently in clinical trials across the UK.

    Under the new agreement, Symbiosis, which employs 100 staff in its Stirling headquarters, will provide manufacturing capacity for the clinical trial which it hopes will accelerate the further development of the vaccine.

    AstraZeneca has said it will provide the drug at cost during the pandemic. The first doses should be available by the end of the year.

    Using manufacturing capacity across the world, including in Scotland, means the company should be able to supply two billion doses if regulatory approval is granted.